Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.34%30B | 31.96%25.56B | 24.84%24.03B | 28.43%91.33B | 44.24%27.99B | 21.18%24.72B | 11.91%19.37B | 37.49%19.25B | 40.89%71.11B | 33.72%19.4B |
| Net income from continuing operations | -82.73%2.71B | 36.18%18.34B | 34.56%16.64B | 59.50%62.36B | 48.66%20.84B | 35.44%15.69B | 72.87%13.47B | 116.66%12.37B | 68.53%39.1B | 201.25%14.02B |
| Depreciation and amortization | 23.24%4.96B | 19.38%4.34B | 15.59%3.9B | 38.65%15.5B | 40.61%4.46B | 40.85%4.03B | 38.66%3.64B | 33.68%3.37B | 28.69%11.18B | 33.50%3.17B |
| Asset impairment expenditure | ---- | ---- | ---- | -84.25%383M | -91.28%95M | -97.65%8M | -82.76%40M | -68.83%240M | 9.65%2.43B | -39.61%1.09B |
| Unrealized gains and losses of investment securities | ---922M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 30.73%5.56B | 4.72%4.83B | 16.42%4.15B | 18.98%16.69B | 24.47%4.26B | 21.71%4.25B | 13.69%4.62B | 16.75%3.56B | 16.97%14.03B | 13.83%3.42B |
| Deferred tax | 1,618.88%19.87B | 28.75%-1.17B | -117.76%-993M | -3,716.79%-4.74B | -14.73%-1.33B | -142.90%-1.31B | -44.42%-1.64B | 26.45%-456M | 103.99%131M | 1.02%-1.16B |
| Other non cashItems | -666.67%-23M | -668.57%-199M | -232.76%-231M | -78.83%87M | -189.47%-119M | -104.05%-3M | -83.41%35M | 2,585.71%174M | -79.26%411M | -93.04%133M |
| Change In working capital | -203.91%-2.15B | -29.15%-957M | 150.67%559M | -72.68%1.05B | 60.35%-504M | 308.04%2.07B | -120.99%-741M | -91.33%223M | -32.50%3.84B | -165.82%-1.27B |
| -Change in receivables | -663.64%-806M | -14.36%-1.34B | 11.27%2.8B | 38.10%-1.49B | -4.75%-2.98B | 121.09%143M | 17.84%-1.17B | -1.02%2.52B | -1,138.53%-2.4B | -67.33%-2.84B |
| -Change in prepaid assets | -461.96%-1.03B | 488.10%326M | 260.00%360M | -224.87%-698M | -175.71%-530M | 79.74%-184M | -55.56%-84M | -87.82%100M | 245.06%559M | -18.13%700M |
| -Change in payables and accrued expense | -68.36%392M | -161.94%-647M | -36.84%-3.27B | -86.44%696M | 553.13%2.09B | 77.25%1.24B | -104.82%-247M | -136.24%-2.39B | 13.79%5.13B | -85.75%320M |
| -Change in other current assets | 213.79%33M | -458.49%-190M | 44.68%-52M | -237.50%-270M | -80.18%-200M | 19.44%-29M | 43.24%53M | -413.33%-94M | 24.53%-80M | -305.56%-111M |
| -Change in other current liabilities | -181.69%-736M | 26.17%892M | 757.83%712M | 349.52%2.81B | 68.02%1.11B | 1,351.39%901M | 568.21%707M | -54.89%83M | -29.57%624M | 39.58%663M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.34%30B | 31.96%25.56B | 24.84%24.03B | 28.43%91.33B | 44.24%27.99B | 21.18%24.72B | 11.91%19.37B | 37.49%19.25B | 40.89%71.11B | 33.72%19.4B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -153.46%-21.85B | -212.82%-25.96B | -129.10%-20.01B | -92.49%-47.15B | -232.17%-21.5B | -41.85%-8.62B | -59.48%-8.3B | -29.53%-8.73B | 15.45%-24.5B | 14.06%-6.47B |
| Net PPE purchase and sale | -128.01%-18.83B | -102.35%-16.54B | -102.20%-12.94B | -37.76%-37.26B | -90.00%-14.43B | -27.12%-8.26B | -33.24%-8.17B | 6.20%-6.4B | 13.28%-27.05B | 15.53%-7.59B |
| Net business purchase and sale | -470.45%-753M | ---- | ---- | 57.07%-270M | 85.94%-9M | -247.37%-132M | 31.33%-57M | 83.78%-72M | 52.06%-629M | -3.23%-64M |
| Net investment purchase and sale | -231.09%-1.18B | -13,688.89%-8.69B | -208.53%-6.98B | -404.59%-9.75B | -695.70%-7.07B | -176.45%-357M | -105.73%-63M | -603.79%-2.26B | -9.34%3.2B | -22.01%1.19B |
| Net other investing changes | -953.54%-1.08B | -1,101.49%-671M | -25.00%-90M | 660.87%129M | 333.33%7M | 1,370.00%127M | 178.82%67M | -196.00%-72M | -475.00%-23M | 0.00%-3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -153.46%-21.85B | -212.82%-25.96B | -129.10%-20.01B | -92.49%-47.15B | -232.17%-21.5B | -41.85%-8.62B | -59.48%-8.3B | -29.53%-8.73B | 15.45%-24.5B | 14.06%-6.47B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -129.86%-10.05B | -42.93%-15.98B | 1.38%-19.5B | -109.13%-40.78B | 34.95%-5.47B | 25.60%-4.37B | -311.22%-11.18B | -87.97%-19.77B | 11.91%-19.5B | -18.99%-8.4B |
| Net issuance payments of debt | -105.74%-545M | -58.53%-474M | -138.41%-751M | 14.41%8.46B | -33.88%-411M | 3,653.56%9.49B | -103.63%-299M | -19.32%-315M | -18.45%7.4B | -30.64%-307M |
| Net common stock issuance | 62.27%-3.33B | -61.41%-10.17B | 15.02%-12.75B | -52.35%-30.13B | --0 | -147.07%-8.82B | -601.45%-6.3B | -60.26%-15.01B | 29.27%-19.77B | 13.42%-5.94B |
| Cash dividends paid | -5.30%-1.33B | -4.82%-1.33B | -4.40%-1.33B | ---5.07B | ---1.27B | ---1.26B | ---1.27B | ---1.27B | --0 | --0 |
| Net other financing activities | -28.24%-4.85B | -20.97%-4.01B | -46.99%-4.66B | -97.21%-14.05B | -75.84%-3.78B | -85.29%-3.78B | -62.05%-3.31B | -257.50%-3.17B | -119.10%-7.12B | -5,763.16%-2.15B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -129.86%-10.05B | -42.93%-15.98B | 1.38%-19.5B | -109.13%-40.78B | 34.95%-5.47B | 25.60%-4.37B | -311.22%-11.18B | -87.97%-19.77B | 11.91%-19.5B | -18.99%-8.4B |
| Net cash flow | ||||||||||
| Beginning cash position | -58.13%13.83B | -9.65%30.07B | 6.10%45.44B | 174.60%42.83B | 19.07%45.13B | 10.81%33.03B | 167.99%33.28B | 174.60%42.83B | -7.52%15.6B | 148.51%37.9B |
| Current changes in cash | -116.16%-1.9B | -15,347.17%-16.37B | -67.25%-15.48B | -87.47%3.4B | -77.38%1.03B | 38.85%11.73B | -100.61%-106M | -183.81%-9.26B | 4,397.62%27.12B | 5,763.75%4.53B |
| Effect of exchange rate changes | -97.55%9M | 186.18%131M | 138.89%112M | -795.58%-786M | -280.30%-714M | 203.95%368M | -985.71%-152M | -438.82%-288M | 117.71%113M | -6.82%396M |
| End cash Position | -73.54%11.94B | -58.13%13.83B | -9.65%30.07B | 6.10%45.44B | 6.10%45.44B | 19.07%45.13B | 10.81%33.03B | 167.99%33.28B | 174.60%42.83B | 174.60%42.83B |
| Free cash from | -32.16%11.17B | -19.42%9.02B | -13.71%11.09B | 22.70%54.07B | 14.82%13.56B | 18.41%16.47B | 0.20%11.2B | 79.04%12.85B | 128.46%44.07B | 106.76%11.81B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.